Regeneron Pharmaceuticals: Post-Earnings Analysis

5/22/17

Source: Finviz

Based on the stock price chart above, it is clear that Regeneron Pharmaceuticals Inc (NASDAQ:REGN) shares are in a upward trend. Shareholders and potential investors of REGN may be interested in knowing what the future holds for their investment, and whether REGN stock rates as a buy, hold or sell?

Given the stock's recent performance, it seemed like a good time to take a closer look at the earnings expectations, peer analysis & valuation and fundamentals. That might help answer whether stock is a good buy or sell in 2017.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.